Risk signal mining of adverse events related to baloxavir marboxil based on the US FDA Adverse Event Reporting System

Bai Xiangrong, Wang Yangai, Chen Bing

PDF(385 KB)
PDF(385 KB)
Adverse Drug Reactions Journal ›› 2023, Vol. 25 ›› Issue (12) : 712-716. DOI: 10.3760/cma.j.cn114015-20230403-00249

Risk signal mining of adverse events related to baloxavir marboxil based on the US FDA Adverse Event Reporting System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 25(12): 712-716 https://doi.org/10.3760/cma.j.cn114015-20230403-00249

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(385 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉